Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

A hospital outbreak of catheter infections in calves was caused by a bacteria from a beef herd, leading to longer hospital stays, more drug use, and calf deaths.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

A sick foal with Rhodococcus equi pneumonia was successfully treated for multiple complications with targeted therapy and careful monitoring.

Horse skin diseases are complex to manage and often require a biopsy for accurate diagnosis and treatment.

Improving how drugs are absorbed through the skin could better treat mange in wombats.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Cancer treatments often cause skin, nail, and hair problems.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Minoxidil, a common alopecia medication, might cause eye changes due to its properties and lack of tissue selectivity.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Epidermal stem cells show promise for future dermatology treatments due to ongoing advancements.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Living with lupus as both a patient and doctor improved understanding and care for others.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

A fungus ball in the lung can cause coughing up blood in SLE patients.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

Vaccines work well in Netherton syndrome patients, similar to healthy people.

CD4+ skin cells may be precursors to basal cell carcinoma.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.